H.R. 2821: FDA Modernization Act 3.0
A House bill (H.R.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | House bill (H.R.) |
| Originating chamber | House |
| Introduced | 2025-04-10 |
| Sponsor | Rep. Carter, Earl L. "Buddy" [R-GA-1] |
| Policy area | Health |
| Cosponsors | 20 |
| Latest action | 2026-07-21 — Received in the Senate. |
| Last updated | 2026-07-29 |
Summary
Official summary (Introduced in House, 2025-04-10):
FDA Modernization Act 3.0
This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.
The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications.
The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
Cosponsors (20)
| Name | Party / state |
|---|---|
| Nanette Diaz Barragán | D CA (original cosponsor) 2025-04-10 |
| Vern Buchanan | R FL (original cosponsor) 2025-04-10 |
| Rosa L. DeLauro | D CT (original cosponsor) 2025-04-10 |
| Diana Harshbarger | R TN (original cosponsor) 2025-04-10 |
| Troy A. Carter | D LA (original cosponsor) 2025-04-10 |
| Lloyd Doggett | D TX 2025-04-14 |
| Jerrold Nadler | D NY 2025-04-17 |
| Mike Carey | R OH 2025-04-17 |
| Brian K. Fitzpatrick | R PA 2025-04-17 |
| Nicole Malliotakis | R NY 2025-04-17 |
| Dan Crenshaw | R TX 2025-04-17 |
| Judy Chu | D CA 2025-04-29 |
| Hillary J. Scholten | D MI 2025-04-29 |
| Darren Soto | D FL 2025-04-29 |
| Daniel S. Goldman | D NY 2025-04-29 |
| Jay Obernolte | R CA 2025-05-13 |
| Josh Gottheimer | D NJ 2025-05-20 |
| Jason Crow | D CO 2025-06-06 |
| Ted Lieu | D CA 2025-06-27 |
| Claudia Tenney | R NY 2025-07-02 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for H.R. 2821 are published by Congress on congress.gov.
View H.R. 2821 on congress.gov →
Frequently asked questions
What is H.R. 2821?
H.R. 2821 is a House bill (H.R.) introduced in the 119th U.S. Congress, originating in the House. Official title: FDA Modernization Act 3.0.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for H.R. 2821 are available on congress.gov.
Bill data: congress.gov API (official congressional records).